Jazz Pharmaceuticals held annual shareholder meeting in Dublin

• Jazz Pharmaceuticals held its annual general meeting on July 23, 2026.
• Shareholders backed three separate director resolutions, returning Bruce C. Cozadd, Heather Ann McSharry, Rick E Winningham to the board.
• KPMG, Dublin was ratified as independent auditor for the year ending Dec. 31, 2026; the audit committee was authorized to set remuneration.
• Investors granted the board authority to allot and issue ordinary shares, including authority to issue shares for cash without statutory pre-emption rights.
• No vote was held on the adjournment resolution tied to soliciting additional proxies for the share-issuance authorities.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jazz Pharmaceuticals plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-049466), on July 24, 2026, and is solely responsible for the information contained therein.